Efficacy and toxicity of high-risk therapy of the Dutch Childhood Oncology Group in childhood acute lymphoblastic leukemia

Keyphrases

• Oncology 100%
• Dutch 100%
• High Risk 100%
• Childhood Acute Lymphoblastic Leukemia 100%
• Minimal Residual Disease 62%
• Disease Level 50%
• Acute Lymphoblastic Leukemia 37%
• Annualized Relapse Rate 37%
• Chemotherapy 25%
• Patient numbers 25%
• Treatment Protocol 12%
• Poor Outcome 12%
• Leukemia Relapse 12%
• Event-free Survival 12%
• Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 12%
• Complete Remission 12%
• MLL4 12%
• Stem Cell Transplantation 12%
• Relapse Rate 12%
• Newly Diagnosed 12%
• High Survival 12%
• High-risk Factors 12%
• Leukemia Risk 12%
• Prednisone Response 12%
• Treatment Intensification 12%
• Low Positive 12%
• High-risk Criteria 12%
• Consolidation Courses 12%

Medicine and Dentistry

• Oncology 100%
• Acute Lymphoblastic Leukemia 100%
• Minimal Residual Disease 100%
• Cumulative Incidence 60%
• Dying 40%
• Chemotherapy 40%
• Leukemia Relapse 20%
• Event Free Survival 20%
• Allogeneic Stem Cell Transplantation 20%
• Stem Cell Therapy 20%
• Recurrence Risk 20%
• Prednisone 20%

Nursing and Health Professions

• Leukemia Relapse 20%